MS
Mohammed Sarfraz Khan
About Mohammed Sarfraz Khan
Data last updated:
Mohammed Sarfraz Khan was a Director at Biorealm Biopharmaceuticals Private Limited (2018–2022), Director at Hippocrat Biotech Private Limited (2017–2022) and Director at G R Pharma Private Limited (2014–2017). The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Biorealm Biopharmaceuticals Private Limited U24299MH2013PTC250679 | Director | 28 Feb 2018 | 2013 | ₹5.25 Cr (FY 2024) | Active |
| Hippocrat Biotech Private Limited U24233MH2013PTC241122 | Director | 29 Jul 2017 | 2013 | ₹19.07 Cr (FY 2024) | Active |
 G R Pharma Private Limited U85300MH2014PTC251911 | Director | 09 Jan 2014 | 2014 | ₹2.94 Cr (FY 2023) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mohammed Sarfraz Khan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mohammed Sarfraz Khan
Mohammed Sarfraz Khan was first appointed on 09 Jan 2014 as Director at G R Pharma Private Limited. The most recent appointment on record is 28 Feb 2018 at Biorealm Biopharmaceuticals Private Limited.
Mohammed Sarfraz Khan held 3 earlier board appointments: Biorealm Biopharmaceuticals Private Limited (Director, 28 Feb 2018 to 25 Apr 2022); Hippocrat Biotech Private Limited (Director, 29 Jul 2017 to 25 Apr 2022); G R Pharma Private Limited (Director, 09 Jan 2014 to 23 Dec 2017).